First Trust Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

First Trust Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-48,986	Closed	-$325K	–	2435
2018 Q4	$325K	Sell	48,986 -93,927	-66%	-$761K	﹤0.01%	2248
2018 Q3	$1.52M	Buy	+142,913	New	+$1.64M	﹤0.01%	1802
2017 Q4	–	Sell	-29,256	Closed	-$360K	–	2433
2017 Q3	$360K	Buy	+29,256	New	+$432K	﹤0.01%	2184
2017 Q1	–	Sell	-120,857	Closed	-$1.67M	–	2427
2016 Q4	$1.67M	Sell	120,857 -4,375	-3%	-$70.2K	0.01%	1557
2016 Q3	$2.26M	Buy	125,232 +34,306	+38%	+$552K	0.01%	1273
2016 Q2	$1.3M	Buy	+90,926	New	+$1.23M	﹤0.01%	1539

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors's LXRX Position: Q1 2019 in Review

First Trust Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2019, closing a stake of 48,986 shares — an estimated $325K sold.

First Trust Advisors first reported a position in LXRX in Q2 2016 and held it in 6 quarters. The position peaked at $2.26M in Q3 2016. 121 funds tracked by Wall St. Rank hold LXRX as of Q1 2019.

First Trust Advisors reported no remaining Lexicon Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
First Trust Advisors sold 48,986 Lexicon Pharmaceuticals shares in Q1 2019, an estimated $325K.
First Trust Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 6 quarters.
First Trust Advisors's Lexicon Pharmaceuticals position peaked at $2.26M in Q3 2016.
121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2019.

Based on First Trust Advisors's 13F filing for Q1 2019, filed 9 May 2019.